AVITA Medical, Inc. Proceeds from Debt, Net of Issuance Costs
AVITA Medical, Inc. (RCEL) reported Proceeds from Debt, Net of Issuance Costs of $49.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-08-06
- AVITA Medical, Inc. proceeds from debt, net of issuance costs for the quarter ending 2026-06-30 was $0.00.
- AVITA Medical, Inc. proceeds from debt, net of issuance costs for the quarter ending 2026-03-31 was $49.08M.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $49.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $49.08M 10-Q · filed 2026-05-14 |